Max Healthcare Q4: Net Profit Soars 86%, Board Approves Final Dividend

Large cap company operating in Hospitals & Allied Services sector, Max Healthcare Institute Ltd on Tuesday announced its net profit surged 86% YoY to Rs 320 crore for the three months ended March 2023, as per the regulatory filing. The company reported its net profit at Rs 172 crore for January-March quarter of last fiscal. Meanwhile, shares of Max Healthcare Institute traded new 52-week high amid robust results. Check details below:

Max Healthcare Institute Announces Dividend: According to the regulatory filing of the company, "recommended final dividend of ₹ 1 /- per equity share (10% of face value of ₹ 10 /- each), out of the profits of the financial year 2022-23, subject to approval of the members of the Company, which shall be paid/ dispatched within 30 days from the conclusion of the ensuing Annual General Meeting."

Max Healthcare Institute Stock Performance & Return: Last trading price of Max Healthcare is Rs 506.90 apiece with intraday fall of 2.49% on BSE. The stock's 52-week high price is Rs 524.85 apiece and 52-week low price is Rs 306.00 apiece, respectively. The company's market capitalisation is Rs 49,224.61 crore. The shares of Max Healthcare soared 19% in last 6-months, 37% in last 1-year, and 130% in last 2-years.

Max Healthcare Q4: Max Healthcare Net revenue soared to Rs 1,551 crore for the fourth quarter as against Rs 1,224 crore declared in the year-ago period, according to the exchange filing. The Delhi-based hospital chain declared its PAT at Rs 1,328 crore for the year ended March 31, 2023 as against Rs 752 crore declared in the corresponding period last fiscal.

Meanwhile, EBITDA was up 44% to Rs 437 crore and EBITDA margin stood at 28.2% against 24.9%.

"The Q4 results are in line with our plan and reflect the flawless execution of our strategy by the team on the ground," said Abhay Soi, chairperson and managing director at Max Healthcare.